Last Tuesday (19), Neuralink, the brain chip startup led by billionaire Elon Musk, announced that it has received approval from an independent review board to begin the first human trial of its brain implant intended for patients with paralysis.
The primary objective of this study is to evaluate both the safety and effectiveness of the brain-computer interface of Neuralink, which is implantable and wireless.
see more
Arbor Day: life asks for help
Can TikTok ban problematic accounts and lives? Expert analyzes the…
The technology aims to allow people with paralysis to control external devices via through their thoughts, representing a significant advance in the area of neuroscience and health care doctor.
Furthermore, Neuralink's objective is to advance scientific research that guarantees the improvement of irreversible diseases. Check details!
Neuralink will begin human testing
Neuralink has reported that patients suffering from paralysis due to cervical spinal cord injuries or amyotrophic lateral sclerosis may meet the criteria to participate in this innovative study.
Through a publication on the official profile, the company clarified that the main focus of these new tests is to thoroughly verify the safety and effectiveness of the brain-computer interface.
This same verification will allow participants to control devices on a computer solely through brain signals.
In May, US lawmakers announced the start of an investigation into how the company oversees testing involving animals.
This investigation reflects growing concern about ethical practices and the welfare of animals used in research and testing and has the objective of ensuring that companies are adhering to strict guidelines and regulations when conducting experiments involving animals.
At Trezeme Digital, we understand the importance of effective communication. We know that every word matters, which is why we strive to deliver content that is relevant, engaging and personalized to meet your needs.
